PRIFTIN NEWS HIGHLIGHTS Media Articles Related to Priftin (Rifapentine)
Tuberculosis Skin Test (PPD Skin Test)
Source: MedicineNet Tuberculosis Specialty [2008.09.02]
Tuberculosis
Source: MedicineNet Erythema Nodosum Specialty [2008.01.17]
Extensively Drug-Resistant Tuberculosis (XDR TB)
Source: MedicineNet ICU Psychosis Specialty [2007.05.30]
On 1 December, The Union Observes The 20th Anniversary Of World AIDS Day And Addresses The Issues Of TB-HIV/AIDS Care
Source: Health News from Medical News Today [2008.12.01]
Research Advance May Lead To New Ways To Attack Latent TB And Other Bacteria
Source: Biology / Biochemistry News From Medical News Today [2008.12.01]
Published Studies Related to Priftin (Rifapentine)
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. [2006.04.15]
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy. [2004.06.01]
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. [2003.05.15]
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment. [2002.06.01]
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. [2002.01]
Clinical Trials Related to Priftin (Rifapentine)
TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine [Completed]
TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection [Recruiting]
Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis [Not yet recruiting]
Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine [Active, not recruiting]
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [Completed]
|
